CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial and craniofacial implants, announced today that it has received premarket approval from the Food and Drug Administration (FDA) for a new 510(k) application that allows for unique modifications to their PEEK cranio-maxillofacial implant product line. This approval means Kelyniam can now sell the only...Read More

To the Shareholders of Kelyniam Global, Inc. Kelyniam achieved record sales in 2018 by growing 15% to $2,123,699, marking two years in a row of double digit growth. Unit sales increased 11% and the average selling price per unit increased nearly 5% over 2017. Despite this success, we were expecting more. Our program to produce...Read More

Kelyniam Global, Inc., (KLYG), a maker of patient specific craniofacial and skull implants, announced the submission of its third 510(k) application to the FDA to expand their line of custom implants. “The 510(k) submission is the result of our significant investments in research and development and in the quality infrastructure to successfully pursue regulatory applications,”...Read More

Kelyniam Global (KLYG), a maker of custom cranial implants, announced the acquisition of new additive manufacturing technology to increase current medical modeling capabilities. “This state-of-the-art equipment will enable Kelyniam to produce certain medical models on the same 24-hour turnaround schedule we offer for cranial implants,” said Chris Breault, Kelyniam’s Chief Operating Officer.  “The ability to rapidly...Read More

Dear Shareholder, 2017 marks the first year since 2014 that the company has published financial information. You can now find financial information for 2015 and 2016 on our website, Kelyniam.com. Reporting financial information is just one example of the many positive changes happening at Kelyniam. I am pleased to report that year over year revenues...Read More

CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, announced today that it has signed a multi-year distribution agreement with a leading medical device distributor in the neuroscience market. Dr. Mark Smith, Kelyniam’s Vice President of Sales said, “This agreement is in alignment with our sales strategy of building long-term relationships with...Read More

CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, announced today that it has hired Ross Bjella as Chairman and Chief Executive Officer. The company had recently appointed Chris Breault as Chief Operating Officer after the former President, Tennyson Anthony, left the company in April of this year. The company has also...Read More

Click here to viewRead More

KLYG 2015 & 2014 YE FinancialsRead More